marketcaparena
Search

    KLRA

    Kailera Therapeutics, Inc.

    Company overview

    Market capitalization
    $1.44B
    Employees
    145
    Latest publication
    2026-09-29
    About Kailera Therapeutics, Inc.

    Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
    Total Revenue0USD0USD
    Research Development70,873,000USD10,130,000USD
    Selling General Administrative13,787,000USD10,328,000USD
    Total Operating Expenses84,660,000USD20,458,000USD
    Operating Income-84,660,000USD-20,458,000USD
    Interest Income5,716,000USD1,675,000USD
    Net Interest Income5,716,000USD1,675,000USD
    Income Before Tax-78,865,000USD-17,983,000USD
    Net Income-78,865,000USD-17,983,000USD
    Net Income From Continuing Ops-78,865,000USD-17,983,000USD
    Reconciled Depreciation101,000USD63,000USD
    Total Other Income Expense Net79,000USD800,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USD
    Total Revenue0USD
    Research Development109,113,000USD
    Selling General Administrative49,227,000USD
    Total Operating Expenses158,340,000USD
    Operating Income-158,340,000USD
    Interest Income11,048,000USD
    Net Interest Income11,048,000USD
    Income Before Tax-148,955,000USD
    Net Income-148,955,000USD
    Net Income From Continuing Ops-148,955,000USD
    Reconciled Depreciation310,000USD
    Total Other Income Expense Net-1,663,000USD
    SourceLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USD
    Total Assets1,211,416,000USD624,756,000USD
    Cash And Equivalents130,301,000USD—
    Cash And Short Term Investments916,741,000USD—
    Short Term Investments786,440,000USD407,348,000USD
    Long Term Investments255,076,000USD62,747,000USD
    Total Current Assets929,167,000USD530,315,000USD
    Other Current Assets395,000USD360,000USD
    Other Non Current Assets90,000USD—
    Total Liabilities92,952,000USD—
    Total Current Liabilities83,651,000USD54,836,000USD
    Other Current Liabilities63,399,000USD—
    Other Non Current Liabilities135,000USD—
    Total Stockholder Equity1,118,464,000USD-432,088,000USD
    Total Equity Including Noncontrolling Interest1,118,464,000USD—
    Property Plant Equipment Net11,651,000USD12,024,000USD
    Accounts Payable19,202,000USD7,095,000USD
    Short Term Debt1,050,000USD—
    Common Stock0USD—
    Retained Earnings-558,840,000USD-447,533,000USD
    Accumulated Other Comprehensive Income-1,794,000USD—
    Total Liab—1,056,844,000USD
    Other Current Liab—722,000USD
    Capital Stock—0USD
    Cash—111,826,000USD
    Property Plant Equipment Gross—12,024,000USD
    Common Stock Shares Outstanding—117,948,773shares
    Non Current Assets Total—94,441,000USD
    Non Current Liabilities Total—1,002,008,000USD
    Non Current Liabilities Other—201,000USD
    Non Currrent Assets Other—6,352,000USD
    Net Working Capital—475,479,000USD
    Unclassified Current Assets—10,781,000USD
    Unclassified Non Current Assets—13,318,000USD
    Unclassified Current Liabilities—47,019,000USD
    Unclassified Non Current Liabilities—1,001,807,000USD
    Unclassified Equity—15,445,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
    Total Assets692,294,000USD178,445,000USD
    Other Current Assets1,234,000USD343,000USD
    Total Liab1,048,752,000USD397,217,000USD
    Total Stockholder Equity-356,458,000USD-218,772,000USD
    Other Current Liab916,000USD2,160,000USD
    Capital Stock0USD0USD
    Retained Earnings-368,668,000USD-219,713,000USD
    Cash160,267,000USD175,178,000USD
    Total Current Assets557,537,000USD177,611,000USD
    Total Current Liabilities46,405,000USD6,911,000USD
    Long Term Investments106,672,000USD0USD
    Short Term Investments385,789,000USD0USD
    Accounts Payable7,529,000USD2,008,000USD
    Property Plant Equipment Net12,418,000USD680,000USD
    Property Plant Equipment Gross12,518,000USD733,000USD
    Common Stock Shares Outstanding117,948,773shares117,948,773shares
    Non Current Assets Total134,757,000USD834,000USD
    Non Current Liabilities Total1,002,347,000USD390,306,000USD
    Non Current Liabilities Other270,000USD—
    Non Currrent Assets Other3,482,000USD154,000USD
    Net Working Capital511,132,000USD170,700,000USD
    Unclassified Current Assets10,247,000USD2,090,000USD
    Unclassified Non Current Assets12,185,000USD—
    Unclassified Current Liabilities37,960,000USD2,743,000USD
    Unclassified Non Current Liabilities1,002,077,000USD390,306,000USD
    Unclassified Equity12,210,000USD—
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
    Net Income-78,865,000USD-17,983,000USD
    Depreciation101,000USD63,000USD
    Stock Based Compensation3,939,000USD1,523,000USD
    Other Non Cash Items274,000USD-20,000USD
    Change In Working Capital7,466,000USD-984,000USD
    Total Cash From Operating Activities-68,310,000USD-18,201,000USD
    Capital Expenditures0USD0USD
    Free Cash Flow-68,310,000USD-18,201,000USD
    Investments22,849,000USD-54,440,000USD
    Total Cash From Financing Activities-2,980,000USD0USD
    Change In Cash-48,441,000USD-72,641,000USD
    Begin Period Cash Flow161,028,000USD175,178,000USD
    End Period Cash Flow112,587,000USD102,537,000USD
    Unclassified Operating Cash Flow-1,225,000USD—
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USD
    Net Income-148,955,000USD
    Depreciation310,000USD
    Stock Based Compensation10,940,000USD
    Other Non Cash Items660,000USD
    Change In Working Capital16,781,000USD
    Total Cash From Operating Activities-120,210,000USD
    Capital Expenditures-2,088,000USD
    Free Cash Flow-122,298,000USD
    Investments-490,511,000USD
    Net Borrowings100,000,000USD
    Total Cash From Financing Activities598,659,000USD
    Issuance Of Capital Stock498,874,000USD
    Change In Cash-14,150,000USD
    Begin Period Cash Flow175,178,000USD
    End Period Cash Flow161,028,000USD
    SourceLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.